Welcome to the “news” section of our website, where you'll find all the latest publications on our advances in research (Alzheimer's, Parkinson's, Charcot's disease, etc.), our upcoming events, etc.
In a study published in the September 2014 issue of the scientific journal Cortex (number 58), Pr. Gianfranco Dalla Barba of the Brain and Spine Institute – Institut du Cerveau - ICM – and his collaborators demonstrated that “confabulators mistake...
Two researchers of the Institut du Cerveau et de la Moelle épinière – Institut du Cerveau - ICM – Brain and Spine Institute, Fabrizio DE VICO FALLANI and Mario CHAVEZ, in collaboration with the University of Grenoble (Sophie ACHARD) and the Stanford...
The Biotechnology & Biotherapy team, created by Dr. Jacques Mallet and presently directed by Dr. Philippe Ravassard, at Paris Brain Institute, in collaboration with the Pole of Therapeutic Innovation in Neuropsychiatry at the Servier Research...
Alzheimer disease is a major source of preoccupation. A real issue for public health at a global scale, its socio-economic consequences are important. Synonym for cognitive deterioration, it is difficult to live with for the patient but also his...
6 genetic risk factors for Parkinson’s disease have been discovered thanks to a study conducted by an international consortium of researchers, including Professor Alexis Brice’s team at the Brain and Spine Institute – Institut du Cerveau - ICM...
A research team of the Institut du Cerveau - ICM institute took part to an international study identifying 18 new genes implicated in hereditary spastic paraplegias (HSP). This work, published on January the 31th on the prestigious website of the...
A paper published in the prestigious journal Brain by a team of the Institut du Cerveau - ICM institute link rapid eye movement sleep disorders and Parkinson’s disease. These results open the possibilities to early diagnose development of the...
Hereditary Spastic Paraplegia (HSP) are a genetically heterogeneous group of invalidating neurological disorders characterized by a progressive difficulty walking due to stiff legs (spastic) and additional neurological signs like epilepsy, ataxia...
The aim of Dr A. Sittler, from the Alexis Brice and Giovanni Stevanin team, is to develop a new therapeutic strategy for the spinocerebellar ataxia SCA7.
A research team directed by Giovanni Stevanin and Alexis Brice from the Brain and Spine Institute, in collaboration with other teams of the international SPATAX network (coordinator, Alexandra Durr), have identified 3 new causative genes in...
